C

CorDx

Global rapid testing & point-of-care diagnostics

Regulatory Affairs Manager

Full-TimeUpdated
No salary listed
Senior
Bachelor's, Master's
Atlanta, GA, USA
In PersonOn-site in Atlanta, Georgia.
Biology & BiotechRegulatory & Quality (Life Sciences)

About the job

Requirements
  • A bachelor's degree in Regulatory Affairs, Life Sciences, Engineering, or a related field is required.
  • Five to seven years of regulatory affairs experience within the medical device or in vitro diagnostics industry.
  • Working knowledge of 510(k) submissions and regulatory documentation processes.
  • Solid understanding of FDA regulations, including 21 CFR Part 820, ISO 13485, and medical device regulatory requirements.
  • Strong organizational and project management skills, with the ability to manage multiple projects and priorities.
  • Ability to work collaboratively in cross-functional teams and manage document workflows.
Responsibilities
  • Prepare, review, and coordinate submissions of regulatory documents, including 510(k) submissions, technical files, and other filings to regulatory agencies.
  • Ensure product compliance with FDA regulations, ISO 13485, and applicable international standards.
  • Provide regulatory guidance to product development teams on applicable regulations and documentation requirements.
  • Monitor changes in regulatory requirements and assist in assessing their impact on company processes and products.
  • Perform regulatory assessments for product changes and propose appropriate regulatory pathways.
  • Maintain documentation and records of regulatory submissions and correspondence.
  • Support preparation for regulatory agency meetings, audits, and inspections.
  • Collaborate with R&D, Quality, and Operations to ensure regulatory deliverables are met in a timely manner.
Desired Qualifications
  • A master's degree is preferred.
  • Experience interacting with the FDA and other regulatory agencies is preferred.

About the company

CorDx is a multinational biotech organization that provides rapid testing and point-of-care diagnostic devices. Its products are designed to quickly detect infectious diseases (like COVID-19), pregnancy, drugs of abuse, biomarkers, and other health indicators directly at the patient’s side. The devices work by offering fast diagnostic tests and wearable or handheld systems that deliver results on-site, often supported by data science and artificial intelligence to improve accuracy and capture health data. CorDx differentiates itself from competitors through its global reach (2,100+ employees in over 100 countries), scale, and its emphasis on integrating AI and data-driven insights to enhance diagnostic solutions. The company aims to help answer critical health questions by delivering practical, accessible diagnostics and moving toward personalized healthcare.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Atlanta, Georgia

Founded

2006

Get referred to CorDx

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CorDx secured an FDA EUA for Tyfast Flu A/B and COVID-19 in 2024.
  • The 2025 Singapore POCT Centre broadens access to infectious, fertility, and chronic-disease programs.
  • CorDx opened a new Singapore facility in 2026, strengthening global manufacturing reach.

What critics are saying

  • FDA authorization still governs key products like Tyfast and COVID-19 Ag under emergency use.
  • Singapore expansion raises fixed costs while diagnostics demand remains volatile after pandemic-era normalization.
  • Any U.S. FDA or EU IVDR setback would strand CorDx's multiplex-test commercialization roadmap.

What makes CorDx unique

  • CorDx spans R&D, manufacturing, and supply chain across the U.S., China, and Singapore.
  • The 2025 DxD Hub POCT Centre deepens CorDx's Singapore diagnostics collaboration.
  • MasterControl adoption signals a compliance-first operating model across global quality and manufacturing systems.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Training Programs
  • Paid Vacation
  • 401(k) Retirement Plan
  • Meal Benefits

Company News

PR Newswire
Oct 23rd, 2024
CorDx Selects MasterControl to Streamline Life Science Quality and Manufacturing Processes Globally

CorDx selects MasterControl to streamline life science quality and manufacturing processes globally.

Business Wire
May 21st, 2024
Cordx’S Aiiso Yufeng Li Family Gifts $21M To Uc San Diego Jacobs School Of Engineering To Further Chemical And Nano Engineering Research, Education, And Student Activities

SAN DIEGO--(BUSINESS WIRE)--CorDx, a biotechnology company that is transforming the global diagnostics industry with innovative RD solutions, a vertically integrated supply chain, and manufacturing footprints in the United States and around the world, today announced a transformative $21M gift to the University of California San Diego’s Jacobs School of Engineering from CorDx founder Aiiso Yufeng Li (Jeff), with support from members of the CorDx family – Li’s wife, Aiiso DongDong Li (Doreen), Mac Chen, Haixia Yang, Monica Hu, and others at CorDx. The gift is designated to support chemical and nano engineering research and education at UC San Diego. In recognition of the gift, which marks a significant milestone in the family’s entrepreneurial and philanthropic journey, UC San Diego is renaming the department that houses the university’s chemical and nano engineers -- the Aiiso Yufeng Li Family Department of Chemical and Nano Engineering. This landmark contribution underscores the family’s unwavering dedication to advancing education and innovation and enhancing people’s lives worldwide. The donation is also a testament to the rise of chemical engineering and nano engineering, which is on a trajectory to soon achieve the same recognition and renown as bioengineering, revolutionizing industries and driving innovation to new heights